Trial Profile
A prospective study to evaluate the efficacy of ranibizumab and combined surgery in neovascular glaucoma patients with vitreous haemorrhage
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Neovascular glaucoma
- Focus Therapeutic Use
- 29 Mar 2016 New trial record